Author

Issei Imoto

Observed name: I. Imoto

Institution: Aichi Cancer Center

Observed institution: Aichi Cancer Center

OpenAlex ID: A5041619852

Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma

2024 · Takahiro Tsujikawa, Kazuchika Ohno, et al. · Frontiers in Immunology · 8

Impaired gating of γ‐ and ε‐AChR respectively causes Escobar syndrome and fast‐channel myasthenia

2023 · Xin‐Ming Shen, Tomohiko Nakata, et al. · Annals of Clinical and Translational Neurology · 5

Phenotype-specific associations of mosaic chromosomal alterations in systemic sclerosis

2026 · Yuki Nishio, Yuki Ishikawa, et al. · Annals of the Rheumatic Diseases · 1

Psychological distress and cancer worry in unaffected relatives undergoing cascade testing with multigene panel testing

2026 · Kaori Kimura, Takeshi Kuwata, et al. · Journal of Human Genetics · 1

Establishment of a comprehensive set of fact sheets for cancer predisposition genes for medical oncologists practicing cancer genome profiling

2025 · Manami Matsukawa, Chikako Tomozawa, et al. · International Journal of Clinical Oncology · 1

LB1120 Phenotype-specific associations of mosaic chromosomal alterations in systemic sclerosis

2026 · Y. Nishio, Y. Ishikawa, et al. · Journal of Investigative Dermatology

Abstract 2272: Dichotomous immunogenetic landscape of lung adenocarcinoma associated with usual interstitial pneumonia.

2026 · Akifumi Mochizuki, Ayako Suzuki, et al. · Cancer Research

Whole-genome and transcriptome landscape of actionable driver-negative lung adenocarcinoma.

2025 · Masahiro Torasawa, Kouya Shiraishi, et al. · Journal of Clinical Oncology

Abstract P6-02-15: Don’t get lost in translation: Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) recommendations for reporting germline cancer susceptibility gene variants in 19 languages – breast cancer as a model

2023 · Arcangela De Nicolo, Diana M. Eccles, et al. · Cancer Research

Acknowledgement to the Reviewers

2022 · Issei Imoto · Human Genome Variation

JS5-1 Particle therapy: past, present, and future

2022 · Issei Imoto · Annals of Oncology

JS4-1 Current status and feature of handling germline findings in cancer genome profiling (CGP) testing

2022 · Issei Imoto · Annals of Oncology

Abstract 5210: Tumor immune characterization identifies age-stratified biomarkers for nivolumab in patients with head and neck squamous cell carcinoma: A nationwide collaborative study in Japan

2022 · Takahiro Tsujikawa, Kazuchika Ohno, et al. · Cancer Research

Detection of presumed germline pathogenic variants of hereditary breast cancer predisposition genes in circulating tumor DNA: SCRUM-Japan MONSTAR-SCREEN.

2022 · Masaya Hattori, Yoichi Naito, et al. · Journal of Clinical Oncology

Op0112 the Ever-largest Asian Gwas for Systemic Sclerosis and Trans-population Meta-analysis Identified Seven Novel Loci and a Candidate Causal Snp in a Cis-regulatory Element of the Fcgr Region

2022 · Y. Ishikawa, N. Tanaka, et al. · Annals of the Rheumatic Diseases

Visualization and unsupervised clustering of emphysema progression using t-SNE analysis of longitudinal CT images and SNPs

2022 · Hidenobu Suzuki, Mikio Matsuhiro, et al. · SPIE Medical Imaging: Computer-Aided Diagnosis

Works count: 16

Citation count: 16

H-index: 2

I10-index: